Amphista Therapeutics to Collaborate with Merck for Discovery and Development of Targeted Protein Degradation Therapeutics

Amphista Therapeutics to Collaborate with Merck for Discovery and Development of Targeted Protein Degradation Therapeutics
4 May 2022
American Pharmaceutical Review – View full story